Tsingke specializes in providing a wide range of biotech services, including DNA and RNA synthesis, gene delivery, protein and antibody services, and gene factory solutions. With a focus on molecular diagnostics, vaccine development, gene editing, gene therapy, and agricultural biotech, Tsingke offers custom solutions tailored to research and industrial needs. The company also provides resources such as technical documents, FAQs, and a citations database, ensuring clients have access to the latest information and research.
1 signal in the last 90 days.
The order this company entered each market — oldest to newest
Sign up to see the full signal feed
How Tsingke Biotech's international expansion compares to its competitors
Tsingke BiotechYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Tsingke BiotechYou | 0 | 0 | -100% | 1 | 12 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
Since 2017, CAR-T therapies have been redefining cancer care, empowering T cells to precisely target and eliminate tumors such as leukemia and lymphoma.💡 In our latest newsletter, we detail how CAR genes are delivered into T cells and review the key approaches, including viral vectors like lentivirus and non-viral methods.📩 Read the full article!#CAR-T #CellTherapy #Immunotherapy #PrecisionMedicine #Biotech #CancerResearch #LivingDrugs ...
Active
Speed and quality are the benchmarks of modern Biopharma R&D. Tsingke Biology delivers both through our Automated Gene Synthesis Production Platform. 🚀Key Technical Advantages:- TSINGKE HELIXTECH Integration: Fully automated workflows for DNA fragments up to 1.5 kb. - Stringent Quality Control: Dedicated facilities for plasmid and bacterial operations to minimize contamination.- Industrial Efficiency: Advanced robotics and workstations reduce manual error and increase throughput. Tsingke Biotec ...
Active
Tsingke Biotech now delivers siRNA unmodified oligos in as fast as 🗓️3 calendar days, compared with the standard market turnaround of 3–6 business days, accelerating your R&D progress.siRNA (small interfering RNA) is a core molecular tool for precise gene silencing and gene function studies. Unmodified oligo siRNA (without chemical modifications) plays a critical role in:- RNAi mechanism research- Gene function validation- High-throughput screening of oligonucleotide drug candidate sequencesAt ...
EndedTsingke Biotech demonstrated integrated AI-driven platforms for gene design, antibody discovery, and biologics production at the 2025 Festival of Biologics in Basel.
Tsingke Biotech showcased accelerated protein and antibody services at PEGS Europe 2025, offering protein generation in 3 days and antibodies in 7 days.
Tsingke Biotech introduced its Zero-Contact Sequences system, a fully automated on-site platform designed to protect sensitive genetic information while enabling secure and efficient biotech R&D through encrypted, untraceable synthesis processes.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Tsingke Biotech's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
